MedPath

BUSULFEX

These highlights do not include all the information needed to use BUSULFEX safely and effectively. See full prescribing information for BUSULFEX. BUSULFEX (busulfan) Injection, for intravenous use Initial U.S. Approval: 1999

Approved
Approval ID

5cb9d285-1803-4a99-946a-d0b239b32df6

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 14, 2023

Manufacturers
FDA

Otsuka America Pharmaceutical, Inc.

DUNS: 008314390

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

busulfan

PRODUCT DETAILS

NDC Product Code59148-070
Application NumberNDA020954
Marketing CategoryC73594
Route of AdministrationINTRAVENOUS
Effective DateMarch 25, 2020
Generic Namebusulfan

INGREDIENTS (3)

BusulfanActive
Quantity: 6 mg in 1 mL
Code: G1LN9045DK
Classification: ACTIB
N,N-dimethylacetamideInactive
Code: JCV5VDB3HY
Classification: IACT
Polyethylene Glycol 400Inactive
Code: B697894SGQ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BUSULFEX - FDA Drug Approval Details